Patents for C07D 309 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings (12,815) |
---|
07/21/1999 | EP0929530A1 Quinazoline derivatives and pharmaceutical compositions containing them |
07/21/1999 | EP0929217A1 Sordarin derivatives |
07/21/1999 | CN1223592A Fluoro labelled anthracyclinone and anthracycline derivatives |
07/21/1999 | CN1044240C Tetrahydro-pyrene compound and nematicide against pine wood nematodes containing the same |
07/20/1999 | US5925772 Cysteine protease inhibitors containing heterocyclic leaving groups |
07/15/1999 | WO1999034793A1 Pyronin antibacterials, process and novel intermediates thereto |
07/15/1999 | WO1999025716A3 Pyranones, method for the production and use thereof |
07/15/1999 | CA2315156A1 Pyronin antibacterials, process and novel intermediates thereto |
07/08/1999 | WO1999033782A1 Anticancer platinum (iv) complexes for oral administration |
07/06/1999 | US5919950 Squarylium compounds, and processes and intermediates for the synthesis of these compounds |
07/06/1999 | US5919819 Dihydropyran derivatives as viral neuraminidase inhibitors |
07/01/1999 | WO1999032468A1 Anilide derivative, production and use thereof |
07/01/1999 | WO1999032225A2 Catalytic composition based on chiral ligands with molybdenum, tungsten or chromium and method for asymmetric alkylation of allylic substrates |
07/01/1999 | WO1999032100A2 Pharmaceutical composition for antagonizing ccr5 comprising anilide derivative |
07/01/1999 | CA2311428A1 Anilide derivative, production and use thereof |
07/01/1999 | CA2309661A1 Catalytic composition based on chiral ligands with molybdenum, tungsten or chromium and method for asymmetric alkylation of allylic substrates |
07/01/1999 | CA2304959A1 Pharmaceutical composition for antagonizing ccr5 comprising anilide derivative |
06/30/1999 | EP0925786A1 Remedies for ischemic diseases |
06/29/1999 | US5917061 Process for producing cyclic ethers by liquid phase reaction |
06/29/1999 | US5917058 Treating open ring hydroxy acid form of the statin with acetic acid in the absence of a strong acid catalyst and in the presence of an antisolvent |
06/29/1999 | US5916975 Reacting a prochiral olefin with sodium hypochlorite a source of oxygen in presence of salen catalyst and isoquinoline n-oxide compound as electron donar ligand; epoxidation |
06/29/1999 | US5916784 Oxidizing a glucamine with oxidizing microbe of species gluconobacter oxydans to produce a 6-(substituted amino)-6-deoxy-alpha-l sorbofuranose |
06/24/1999 | WO1999031075A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
06/24/1999 | WO1999031074A2 ((cyclo)alkyl substituted)-.gamma.-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders |
06/24/1999 | WO1999031057A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
06/24/1999 | WO1999031037A1 Apoptosis inhibitors |
06/24/1999 | CA2314954A1 Apoptosis inhibitors |
06/22/1999 | US5914344 Substituted carboxanilide derivative and plant disease control agent comprising same as active ingredient |
06/19/1999 | CA2256303A1 The use of mmp inhibitors for the treatment of ocular angiogenesis |
06/17/1999 | WO1999029681A1 Hydroxylamine derivatives |
06/09/1999 | EP0739403B1 Polymerizable chiral compounds and their use |
06/09/1999 | CN1218805A Process for preparing penta or hexa cyclic ether, particularly dehydropolyol |
06/03/1999 | WO1999026614A1 Substituted 2-aminoacetamides and the use thereof |
06/01/1999 | US5908941 Reactin a chemical intermediate with an acid in presence of an aprotic solvent |
06/01/1999 | US5908863 Geminal carboxylic acids and esters thereof pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism |
06/01/1999 | US5908581 Fluorescent material |
05/27/1999 | WO1999025716A2 Pyranones, method for the production and use thereof |
05/27/1999 | WO1999025687A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
05/27/1999 | WO1999025365A1 Use of ketolides for preparing arterial thrombotic complications related to atherosclerosis |
05/27/1999 | CA2310244A1 Pyranones, methods of preparing and using them |
05/27/1999 | CA2306460A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
05/26/1999 | EP0917587A1 A new method for producing pravastatin precursor, ml-236b |
05/26/1999 | EP0777663B1 Use of substituted 6-amino-4h-pyrans |
05/25/1999 | US5907048 Reacting an aldehyde with conjugated diene in presence of lewis acid catalyst and a co-catalyst selected from a base and a compound such as an ester, chloro-acetic ester, ether, ketone, carbonate, capable of dissolving lewis acid |
05/20/1999 | WO1999024437A1 Novel substituted phenyl keto enols |
05/20/1999 | WO1999024399A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
05/20/1999 | WO1999024386A1 Prins reaction products of 5,7-dimethyl-oct-6-en-2-one and their use as fragrance materials |
05/20/1999 | WO1999024030A1 Novel trienyl compounds |
05/20/1999 | WO1998023574A8 Asiatic acid derivatives and medicines for treating wounds, which contains the same |
05/20/1999 | DE19751200A1 New epothilone derivatives |
05/20/1999 | DE19750623A1 New 2H-1-pyran-2-one derivatives useful as anticonvulsants and neuroprotectants |
05/20/1999 | CA2308359A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
05/19/1999 | EP0916664A1 Enynes used in the synthesis of antifungal agents |
05/19/1999 | EP0915846A2 2- and 2,5-substituted phenylketoenols |
05/19/1999 | EP0915825A2 Substituted tetrahydronaphthalene and dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity |
05/19/1999 | CN1043425C Sub-salicylic amino transition metal compounding agent and it mfg. method |
05/18/1999 | CA2109744C 1-phenylbicyclo¬2.2.2|octane derivatives, a process for their preparation and pharmaceutical compositions holding same |
05/14/1999 | WO1999023089A1 Recovery of gamma-pyrones |
05/14/1999 | WO1999023088A1 Vinyl ether derivatives |
05/14/1999 | WO1999023063A1 Substituted anilides |
05/14/1999 | WO1999007692A3 New epothilone derivatives, method for producing same and their pharmaceutical use |
05/14/1999 | WO1999001423A8 Glucagon antagonists/inverse agonists |
05/12/1999 | EP0915091A2 Process of preparation of five- or sixmembered cyclic ethers, in particular anhydropolyols |
05/12/1999 | EP0654037B1 Antiretroviral enantiomeric nucleotide analogs |
05/12/1999 | DE19749720A1 Neue substituierte Phenylketoenole New substituted Phenylketoenole |
05/06/1999 | WO1999021816A1 Novel liquid-crystal compounds having large negative value of permittivity anisotropy, liquid-crystal composition, and liquid-crystal display element |
05/06/1999 | EP0912655A1 Liquid crystalline saccharose derivatives |
05/06/1999 | DE19749717A1 New epothilone derivatives |
05/04/1999 | US5900415 Dietetic and cardiovascular disorders |
05/04/1999 | CA2074641C Method of treating ocular inflammation |
04/29/1999 | DE19748928A1 New epothilone derivatives |
04/28/1999 | EP0910415A1 Fluoro labelled anthracyclinone and anthracycline derivatives |
04/28/1999 | CN1215390A Substituted phenyl keto enols as pesticides and herbicides |
04/27/1999 | CA2100800C Process for the production of 6e-leucotriene b4 and intermediary products of the said production process |
04/22/1999 | WO1999019318A1 Chromone compounds and use thereof |
04/22/1999 | WO1999019296A1 Aminobutanoic acid derivatives |
04/22/1999 | WO1999006361A3 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
04/22/1999 | WO1999002146A8 Amino acid derivatives |
04/22/1999 | DE19745442A1 Production of lactones from cyclic ketones using organic acid ion exchanger as a solid catalyst for liquid phase oxidation, for use as fiber precursors |
04/06/1999 | US5892113 Protease inhibitors |
04/06/1999 | US5892059 Process for producing a rose oxide |
04/06/1999 | US5891862 Polyvalent polymers for the treatment of rotavirus infection |
04/01/1999 | WO1999015487A1 Benzyl-biphenyls and analogous compounds and the application thereof in order to treat arteriosclerosis and dyslipidaemia |
04/01/1999 | CA2304274A1 Benzyl-biphenyls and analogous compounds and the application thereof in order to treat arteriosclerosis and dyslipidaemia |
03/31/1999 | EP0637298B1 Substituted cyclohexene-1,2-bicarboxylic acid derivatives and raw materials for producing them |
03/30/1999 | CA2144313C 4-hydroxy-2-cyclopentenone derivative and carcinostatic and osteogenesis promoter containing the same |
03/25/1999 | WO1999014211A1 α-PYRONES FOR TREATING α-PYRONE RESPONSIVE STATES |
03/25/1999 | WO1999014210A1 Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones |
03/25/1999 | WO1999014185A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments |
03/25/1999 | DE19741400A1 New benzyl-biphenyl derivatives |
03/25/1999 | CA2303323A1 Compounds containing six-membered rings, processes for their preparation, and their use as medicaments |
03/23/1999 | US5886242 Dopes for nematic or cholesteric liquid crystals in order to produce layers which reflect in colors; comprising a polyvalent chiral group, at least one unsaturated group, at least one spacer and at least one mesogenic polyvalent chiral |
03/23/1999 | US5886240 Process for preparing aromatic acetylenes using palladacycles as catalysts |
03/18/1999 | WO1999012919A1 Process to produce 4-hydroxy-2-oxo-pyrane derivates useful as protease inhibitors |
03/17/1999 | EP0901498A2 Method for synthesizing c-glycosides of ulosonic acids |
03/17/1999 | EP0901493A1 Process for the preparation of an indacene compound |
03/16/1999 | US5883251 Enzyme inhibitors |
03/16/1999 | US5883106 5-lipoxygenase inhibitors |
03/16/1999 | US5883096 Di-n-substituted piperazine derivatives; alzheimer*s disease, cognition activators; synergistic mixtures with acetylcholinesterase inhibitors |
03/16/1999 | CA1340452C Novel hmg-coa reductase inhibitors |